![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study. - Abstract - Europe PMC Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7158913/bin/jcad_13_2_E69_g006.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study. - Abstract - Europe PMC
![Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2012/78/1/Images/ijdvl_2012_78_1_68_90949_f9.jpg)
Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://gnq.fic.mybluehost.me/jcad-online-backup/wp-content/uploads/ShahFeb2020Figure1.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://gnq.fic.mybluehost.me/jcad-online-backup/wp-content/uploads/ShahFeb2020Figure4.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204015774-gr1.jpg)
Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect
![Tacrolimus-treated side at (A) baseline and (B) 6 months' follow-up.... | Download Scientific Diagram Tacrolimus-treated side at (A) baseline and (B) 6 months' follow-up.... | Download Scientific Diagram](https://www.researchgate.net/publication/304779634/figure/fig1/AS:614037326934018@1523409315047/Tacrolimus-treated-side-at-A-baseline-and-B-6-months-follow-up-Mometasone-furoate.png)
Tacrolimus-treated side at (A) baseline and (B) 6 months' follow-up.... | Download Scientific Diagram
![Atopic dermatitis of the face and neck in an 18-year-old woman before... | Download Scientific Diagram Atopic dermatitis of the face and neck in an 18-year-old woman before... | Download Scientific Diagram](https://www.researchgate.net/publication/12393210/figure/fig1/AS:352445109686277@1461040870331/Atopic-dermatitis-of-the-face-and-neck-in-an-18-year-old-woman-before-treatment-A-and-B.png)
Atopic dermatitis of the face and neck in an 18-year-old woman before... | Download Scientific Diagram
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase](https://aerolase.com/wp-content/uploads/2022/08/Figure-11-vitiligo-200x223.png)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure6.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology
![Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Pharmacy Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Pharmacy](https://pubmiddleware.mims.com/resource/image/63E9831B-1440-4FFD-8968-ACCB00343E2A/OriginalThumbnail/THUMBNAIL_shutterstock_1080517253.jpg)
Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Pharmacy
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase](https://aerolase.com/wp-content/uploads/2022/08/Figure-12-vitiligo-200x213.png)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase
![What is Protopic Ointment, Tacrolimus, How it can help fight Vitiligo and Eczema, What is Vitilig... What is Protopic Ointment, Tacrolimus, How it can help fight Vitiligo and Eczema, What is Vitilig...](https://i.ytimg.com/vi/Ul3LV6NIhxA/maxresdefault.jpg)
What is Protopic Ointment, Tacrolimus, How it can help fight Vitiligo and Eczema, What is Vitilig...
![Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2012/78/1/Images/ijdvl_2012_78_1_68_90949_f8.jpg)
Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology
![Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study | Clinical Drug Investigation Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study | Clinical Drug Investigation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40261-019-00845-x/MediaObjects/40261_2019_845_Fig1_HTML.jpg)
Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study | Clinical Drug Investigation
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure12.jpg)